PHENTERMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phentermine Hydrochloride, and what generic alternatives are available?
Phentermine Hydrochloride is a drug marketed by Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Kvk Tech, Lannett, Lannett Co Inc, Nuvo Pharm, Sandoz, Sun Pharm Industries, Teva, Tg United Inc, Upsher Smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms, Actavis Elizabeth, Kvk Tech Inc, Merro Pharm Usa, Novast Labs, Prinston Inc, Sandoz Inc, and Sun Pharm Inds Inc. and is included in eighty-seven NDAs.
The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phentermine Hydrochloride
A generic version of PHENTERMINE HYDROCHLORIDE was approved as phentermine hydrochloride by ELITE LABS INC on May 30th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENTERMINE HYDROCHLORIDE?
- What are the global sales for PHENTERMINE HYDROCHLORIDE?
- What is Average Wholesale Price for PHENTERMINE HYDROCHLORIDE?
Summary for PHENTERMINE HYDROCHLORIDE
![PHENTERMINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for PHENTERMINE HYDROCHLORIDE](/p/graph/s/t/PHENTERMINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for PHENTERMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 4 |
Johns Hopkins University | Phase 4 |
WW International Inc. | Phase 4 |
Pharmacology for PHENTERMINE HYDROCHLORIDE
Drug Class | Sympathomimetic Amine Anorectic |
Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Anatomical Therapeutic Chemical (ATC) Classes for PHENTERMINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for PHENTERMINE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SUPRENZA | Orally Disintegrating Tablets | phentermine hydrochloride | 37.5 mg | 202088 | 1 | 2013-03-22 |
SUPRENZA | Orally Disintegrating Tablets | phentermine hydrochloride | 15 mg and 30 mg | 202088 | 1 | 2012-10-19 |